Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-22-012388
Filing Date
2022-05-13
Accepted
2022-05-13 16:46:09
Documents
6
Effectiveness Date
2022-05-13
Reference 429
333-252155

Document Format Files

Seq Description Document Type Size
1 FORM S-8 nby20220511_s8.htm S-8 88730
2 EXHIBIT 5.1 ex_374900.htm EX-5.1 11356
3 EXHIBIT 23.1 ex_374821.htm EX-23.1 3046
4 EXHIBIT 23.2 ex_374822.htm EX-23.2 2423
5 EXHIBIT FILING FEES ex_374823.htm EX-FILING FEES 14085
6 spb1.jpg GRAPHIC 5365
  Complete submission text file 0001437749-22-012388.txt   128252
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264953 | Film No.: 22923535
SIC: 2834 Pharmaceutical Preparations